Vaping medical marijuana

Postgraduate Medicine

Volumn 130, Issue 2, 2018, Pages 183-185

  Singh, Devina ^a   Lippmann, Steven ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

aerosols; cannabinoids; cannabis; inhaling cannabinoid; Marijuana; vaping

Indexed keywords

BENZO[A]PYRENE; BENZ[A]ANTHRACENE; CANNABIDIOL; CANNABIS; CIGARETTE SMOKE; NICOTINE; OLIVE OIL; PETROLEUM ETHER; RECREATIONAL DRUG; TERPENE; TETRAHYDROCANNABINOL; MEDICAL CANNABIS;

ANXIETY; CANNABIS ADDICTION; CANNABIS SATIVA; CANNABIS SMOKING; CANNABIS-INDUCED PSYCHOSIS; CARCINOGENIC ACTIVITY; CHRONIC BRONCHITIS; COGNITIVE DEFECT; DEPRESSION; EDITORIAL; ELECTRONIC CIGARETTE; HALLUCINATION; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PANIC; SUICIDAL BEHAVIOR; VAPING; INHALATIONAL DRUG ADMINISTRATION;

ADMINISTRATION, INHALATION; HUMANS; MEDICAL MARIJUANA; VAPING;

EID: 85037997832     PISSN: 00325481     EISSN: 19419260     Source Type: Journal    
DOI: 10.1080/00325481.2018.1413281     Document Type: Editorial

References (19)

1. Rong C, Lee Y, Carmona NE, et al. Cannabidiol in medical marijuana: research vistas and potential opportunities. Pharmacol Res. 2017;121:213–218.
2. Park JY, Wu LT., Prevalence, reasons, perceived effects, and correlates of medical marijuana use: a review. Drug Alcohol Depend. 2017;177:1–13.
3. The National Academies of Sciences E, and Medicine. The health effects of cannabis and cannabinoids. Washington (DC): THE NATIONAL ACADEMIES PRESS; 2017. [cited 2017 Aug26].
4. Murnion B., Medicinal cannabis. Aust Prescr. 2015;38(6):212–215.
5. Cranford JA, Bohnert KM, Perron BE, et al. Prevalence and correlates of “Vaping” as a route of cannabis administration in medical cannabis patients. Drug Alcohol Depend. 2016;169:41–47.
6. Whiting PF, Wolff RF, Deshpande S, et al. Cannabinoids for medical use: a systematic review and meta-analysis. JAMA. 2015;313(24):2456–2473.
7. Schauer GL, King BA, Bunnell RE, et al. Toking, vaping, and eating for health or fun: marijuana use patterns in adults, U.S., 2014. Am J Prev Med. 2016;50(1):1–8.
8. Varlet V, Concha-Lozano N, Berthet A, et al. Drug vaping applied to cannabis: is “Cannavaping” a therapeutic alternative to marijuana? Sci Rep. 2016;6:25599.
9. Lee DC, Crosier BS, Borodovsky JT, et al. Online survey characterizing vaporizer use among cannabis users. Drug Alcohol Depend. 2016;159:227–233.
10. Jorge LL, Feres CC, Teles VE. Topical preparations for pain relief: efficacy and patient adherence. J Pain Res. 2010;4:11–24.
11. Budney AJ, Sargent JD, Lee DC. Vaping cannabis (marijuana): parallel concerns to e-cigs? Addiction. 2015;110(11):1699–1704.
12. Romano LL, Hazekamp A. Cannabis Oil: chemical evaluation of an upcoming cannabis-based medicine. Cannabinoids. 2013;1(1):1–11.
13. Giroud C, de Cesare M, Berthet A, et al. E-Cigarettes: a review of new trends in cannabis use. Int J Environ Res Public Health. 2015;12(8):9988–10008.
14. Malouff JM, Rooke SE, Copeland J. Experiences of marijuana-vaporizer users. Subst Abus. 2014;35(2):127–128.
15. Cox B. Can the research community respond adequately to the health risks of vaping? Addiction. 2015;110(11):1708–1709.
16. Meier MH, Caspi A, Ambler A, et al. Persistent cannabis users show neuropsychological decline from childhood to midlife. Proc Natl Acad Sci U S A. 2012;109(40):E2657–E2664.
17. Gilman JM, Kuster JK, Lee S, et al. Cannabis use is quantitatively associated with nucleus accumbens and amygdala abnormalities in young adult recreational users. J Neurosci. 2014;34(16):5529–5538.
18. World Health Organization. The health and social effects of nonmedical cannabis use. Geneva: World Health Organization; 2016. [cited 2017 Aug26]. Available from: http://apps.who.int/iris/bitstream/10665/251056/1/9789241510240-eng.pdf?ua=1
19. Grant KS, Petroff R, Isoherranen N, et al. Cannabis use during pregnancy: pharmacokinetics and effects on child development. Pharmacol Ther. 2017 Aug 25. pii: S0163-7258(17)30224-3. [Epub ahead of print]. DOI:10.1016/j.pharmthera.2017.08.014